HIV type-1 entry inhibitors with a new mode of action
- PMID: 19641233
- DOI: 10.1177/095632020901900604
HIV type-1 entry inhibitors with a new mode of action
Abstract
Background: The development of antiviral drugs has provided crucial new means to mitigate or relieve the debilitating effects of many viral pathogens. Regular use of these drugs has led to generation of resistant strains, making the control of many viral infections very difficult, particularly in HIV-seropositive and AIDS patients. A rich source for the discovery of new HIV infection inhibitors has been, and continues to be, the 'mining' of the large diversity of compounds already available in nature, and specifically those from botanical extracts.
Methods: Using a newly developed direct binding assay with mass spectrometry technology (direct analysis in real-time time-of-flight mass spectrometry), we were able to show that compounds present in extracts of elderberry, cinnamon and green tea bind to and block HIV type-1 (HIV-1) infection in target cells.
Results: The compounds that blocked HIV-1 infection were flavonoids and A-type proanthocyanidins. The 50% inhibitory concentration values of these extracts ranged from 0.5 to 201 microg/ml for four different HIV-1 serotypes. Interaction matrices with the elderberry extract and enfuvirtide, a peptide HIV-1 fusion inhibitor, revealed significant super additive effects. This indicates that the compounds in elderberry that prevent HIV-1 infection are likely to bind to viral glycoproteins other than gp41 (the binding site for enfuvirtide).
Conclusions: Optimized elderberry, green tea and cinnamon extracts rich in certain flavonoid compounds were shown to block HIV-1 entry and infection in GHOST cells. As such, these types of botanical extracts could provide a starting point for the development of possible safe and reliable cotherapies for HIV-1-positive individuals, as well as for the identification of new small molecules as leading drug candidates for HIV-1 therapeutics and microbicides.
Similar articles
-
A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.Fitoterapia. 2012 Mar;83(2):348-55. doi: 10.1016/j.fitote.2011.11.016. Epub 2011 Dec 3. Fitoterapia. 2012. PMID: 22155187
-
A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.PLoS One. 2012;7(7):e41235. doi: 10.1371/journal.pone.0041235. Epub 2012 Jul 23. PLoS One. 2012. PMID: 22844444 Free PMC article.
-
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.J Virol. 2007 Apr;81(7):3240-50. doi: 10.1128/JVI.02413-06. Epub 2007 Jan 24. J Virol. 2007. PMID: 17251281 Free PMC article.
-
Inhibitors of viral entry.Handb Exp Pharmacol. 2009;(189):177-202. doi: 10.1007/978-3-540-79086-0_7. Handb Exp Pharmacol. 2009. PMID: 19048201 Review.
-
Resistance to enfuvirtide, the first HIV fusion inhibitor.J Antimicrob Chemother. 2004 Aug;54(2):333-40. doi: 10.1093/jac/dkh330. Epub 2004 Jul 1. J Antimicrob Chemother. 2004. PMID: 15231762 Review.
Cited by 6 articles
-
Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases.Biomed Res Int. 2018 Jul 17;2018:9105261. doi: 10.1155/2018/9105261. eCollection 2018. Biomed Res Int. 2018. PMID: 30105263 Free PMC article. Review.
-
Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro.PLoS One. 2018 Feb 28;13(2):e0193309. doi: 10.1371/journal.pone.0193309. eCollection 2018. PLoS One. 2018. PMID: 29489892 Free PMC article.
-
A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.PLoS One. 2016 Oct 27;11(10):e0165386. doi: 10.1371/journal.pone.0165386. eCollection 2016. PLoS One. 2016. PMID: 27788205 Free PMC article.
-
Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.Antivir Chem Chemother. 2015 Feb;24(1):28-38. doi: 10.1177/2040206614566580. Antivir Chem Chemother. 2015. PMID: 26149264 Free PMC article.
-
Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.Gene Ther. 2013 Jul;20(7):695-702. doi: 10.1038/gt.2012.98. Epub 2013 Jan 31. Gene Ther. 2013. PMID: 23364313 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical